Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Atrisone completes pivotal phase III acne studies

Jan. 8, 2004

Topical tacrolimus reported effective for oral lichen planus and facial psoriasis

Dec. 30, 2003

PMA filing commences for OrCel for venous leg ulcers

Dec. 30, 2003

Connetics submits NDA for Actiza

Dec. 30, 2003

PVAC development for psoriasis discontinued

Dec. 30, 2003

Disappointing results for HuMax-CD4 in phase IIb psoriasis trial

Dec. 17, 2003

Finacea approved in E.U. as topical treatment of papulopustular rosacea

Dec. 17, 2003

Fujisawa launches pediatric Protopic in Japan

Dec. 16, 2003

OrCel achieves primary and secondary endpoints in venous leg ulcer study

Dec. 15, 2003

Novactyl seeks licensing partner for PCL-016

Dec. 11, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...